Table 3 Predictors of anemia in HIV Infected patients at before HAART initiation at Zewditu Memorial, Addis Ababa, Ethiopia 2012
Variable | Crude OR (95% CI) | AOR (95% CI) |
|---|---|---|
Gender | Â | Â |
Female | 1.00 | 1.00 |
Male | 1.67 (1.30-2.14) | 1.55 (1.18-2.03) |
Age (in years) | Â | Â |
15-24 | 1.00 | 1.00 |
25-34 | 0.99 (0.58-1.71) | 0.99 (0.56-1.77) |
35-44 | 1.46 (0.85-2.52) | 1.46 (0.82-2.60) |
45-54 | 1.40 (0.77-2.55) | 1.21 (0.64-2.29) |
55+ | 2.40 (1.06-5.41) | 2.06 (0.88-4.82) |
WHO clinical stage | Â | Â |
Stage I/II | 1.00 | 1.00 |
Stage III/IV | 2.35 (1.81-3.06) | 2.03 (1.45-2.83) |
CD4 cell count (cells/mm 3 ) | Â | Â |
≥350 | 1.00 | 1.00 |
200-350 | 0.13 (0.03-0.47) | 0.16 (0.04-0.61) |
0-199 | 0.22 (0.06-0.81) | 0.25 (0.07-0.93) |
BMI | Â | Â |
Normal | 1.00 | 1.00 |
Underweight | 2.32 (1.24-4.36) | 1.83 (0.92-3.65) |
Overweight | 0.95 (0.42-2.12) | 1.14 (0.49-2.65) |
OI | Â | Â |
Candidiasis | 1.44 (1.08-1.91) | 1.09 (0.78-1.52) |
Herpes zoster | 0.86 (0.65-1.14) | 0.86 (0.64-1.17) |
TB | 2.07 (1.54-2.80) | 1.52 (1.08-2.13) |
Diarrhea | 0.87 (0.52-1.46) | 0.72 (0.40-1.32) |
Fever | 1.19 (0.67-2.11) | 1.00 (0.52-1.96) |
Pneumonia | 1.84 (0.91-3.71) | 1.94 (0.90-4.18) |
Toxoplasmosis | 1.34 (0.50-3.59) | 1.03 (0.36-2.93) |